Sens. Sununu, Wyden Introduce Bill That Would Account for DTC Ads in Drug Firms' Costs Reporting to Fed Programs

Main Category: Pharma Industry / Biotech Industry
Article Date: 30 May 2005 - 0:00 PDT

email to a friend   printer friendly   opinions  

Senators John Sununu (R-NH) and Ron Wyden (D-Ore) on Thursday introduced a bill that would require pharmaceutical companies to eliminate advertising expenses from the calculation of drug costs for federal programs such as Medicaid, the... Washington Times reports. The proposal also would require HHS Secretary Mike Leavitt and Department of Veterans Affairs Secretary Jim Nicholson to negotiate reduced prices for government health care programs purchasing drugs that are advertised directly to consumers. The bill does not affect the 2003 Medicare law, which forbids price controls on drugs. However, the bill does mandate that HHS develop a report on how the government could reduce advertising-related costs for medications covered under the new Medicare drug benefit. Sununu said the bill's purpose is to eliminate advertising costs that are passed on to taxpayers. Wyden said that because all U.S. businesses receive tax deductions for their advertising costs, "[t]axpayers shouldn't have to further subsidize the drug companies' marketing efforts through Medicare and Medicaid." Pharmaceutical Research and Manufacturers of America spokesperson Jeff Trewhitt said, "The legislation is simply misguided," adding that drug companies spend 10 times more on research and development than they spend on advertising (Higgins, Washington Times, 5/27).

"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations